Singular Health Group Ltd

ASX:SHG Stock Report

Market Cap: AU$90.6m

Singular Health Group Management

Management criteria checks 2/4

Singular Health Group's CEO is Denning Chong, appointed in Apr 2023, has a tenure of 2.58 years. total yearly compensation is A$2.54M, comprised of 9.8% salary and 90.2% bonuses, including company stock and options. directly owns 5.58% of the company’s shares, worth A$5.05M. The average tenure of the management team and the board of directors is 2 years and 4.8 years respectively.

Key information

Denning Chong

Chief executive officer

AU$2.5m

Total compensation

CEO salary percentage9.84%
CEO tenure2.6yrs
CEO ownership5.6%
Management average tenure2yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

We're Not Worried About Singular Health Group's (ASX:SHG) Cash Burn

Oct 14
We're Not Worried About Singular Health Group's (ASX:SHG) Cash Burn

We Think Singular Health Group (ASX:SHG) Can Afford To Drive Business Growth

Jun 16
We Think Singular Health Group (ASX:SHG) Can Afford To Drive Business Growth

We Think Singular Health Group (ASX:SHG) Can Afford To Drive Business Growth

Mar 02
We Think Singular Health Group (ASX:SHG) Can Afford To Drive Business Growth

We're Hopeful That Singular Health Group (ASX:SHG) Will Use Its Cash Wisely

Jan 11
We're Hopeful That Singular Health Group (ASX:SHG) Will Use Its Cash Wisely

Singular Health Group (ASX:SHG) Is In A Good Position To Deliver On Growth Plans

Sep 15
Singular Health Group (ASX:SHG) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has Denning Chong's remuneration changed compared to Singular Health Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025AU$3mAU$250k

-AU$6m

Mar 31 2025n/an/a

-AU$5m

Dec 31 2024n/an/a

-AU$4m

Sep 30 2024n/an/a

-AU$3m

Jun 30 2024AU$626kAU$30k

-AU$3m

Dec 31 2023n/an/a

-AU$3m

Sep 30 2023n/an/a

-AU$4m

Jun 30 2023AU$544kAU$149k

-AU$5m

Mar 31 2023n/an/a

-AU$6m

Dec 31 2022n/an/a

-AU$6m

Sep 30 2022n/an/a

-AU$6m

Jun 30 2022AU$407kn/a

-AU$6m

Mar 31 2022n/an/a

-AU$6m

Dec 31 2021n/an/a

-AU$6m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021AU$229kn/a

-AU$4m

Compensation vs Market: Denning's total compensation ($USD1.65M) is above average for companies of similar size in the Australian market ($USD296.98K).

Compensation vs Earnings: Denning's compensation has increased whilst the company is unprofitable.


CEO

Denning Chong

2.6yrs
Tenure
AU$2,539,867
Compensation

Mr. Denning Chong is MD & CEO of Singular Health Group Ltd from October 2023. He was Interim MD & CEO of Singular Health Group Ltd since April 14, 2023 until October 2023. He is Co-Founder of Singular Heal...


Leadership Team

NamePositionTenureCompensationOwnership
Denning Chong
Co-Founder2.6yrsAU$2.54m5.58%
A$ 5.1m
Kyla Garic
Chief Financial Officer2yrsno data0.0089%
A$ 8.0k
Martina Mariano
Chief Operating Officerless than a yearAU$254.64k0.48%
A$ 435.0k
2.0yrs
Average Tenure

Experienced Management: SHG's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Denning Chong
Co-Founder5.8yrsAU$2.54m5.58%
A$ 5.1m
Howard Digby
Independent Non-Executive Chairman4.8yrsAU$125.98k0.22%
A$ 197.4k
Andrew Just
Independent Non-Executive Director4.8yrsAU$114.83k0.11%
A$ 97.5k
Jonathan Clark
Founding Advisory Board Member4.2yrsno datano data
Bradley Moore
Member of Medical Advisory Board4.1yrsno datano data
4.8yrs
Average Tenure

Experienced Board: SHG's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/19 00:06
End of Day Share Price 2025/11/19 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Singular Health Group Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.